GLP-1 receptor agonists hold key market opportunities due to their effectiveness in diabetes and obesity management, ...
Our easy-to-read fact sheet provides clinicians with an overview of the mechanism of GLP-1 agonists. Our easy-to-read fact sheets provide clinicians with reliable information to share with patients ...
Please provide your email address to receive an email when new articles are posted on . Retatrutide, a GLP-1/GIP/glucagon receptor agonist, was linked to improved health-related quality of life and ...
Palatin Presents Promising Preclinical Data for Melanocortin Agonist PL9588 at ARVO 2025, Highlighting a Dual-Action Glaucoma Therapy By Palatin Technologies, Inc. May 5, 2025 Updated May 5, 2025 ...
Michael Thorpy, MD, professor of neurology, Albert Einstein College of Medicine, explored the mechanism of action in orexin agonists, which has been indicated for idiopathic hypersomnia. One of the ...
Tyligand Bioscience Ltd. has reported data on TSN-222, their new cyclic dinucleotide designed as a dual-action tumor immune agonist (DATIA) compound. TSN-222 activates the STING pathway in tumoral ...
Peer-reviewed study characterizes in vitro and ex vivo activities of novel antibody agonists generated using Abalone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results